Home›Companies›Biotech & Pharma›Codagenix

Codagenix Inc.

Updated Oct 29, 2026·Latest SEC filing Feb 27, 2023·Suggest an edit

About Codagenix

Codagenix is a private company based in Farmingdale, New York. It has reported $25,005,232 raised in one offering on Form D since February 2023. Its chief executive is John Coleman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 10, 2023Feb 27, 2023$25,005,232fully sold5$5.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Codagenix's Form D filed Feb 27, 2023.

CP
SW
JH
Jill Howe
Director
JC
John Coleman
Chief Executive Officer and director
SM
PG
Paul Grint
Director
GR
TC
Tyler Cook
Executive officer

Sources

  1. SECCodagenix Inc. filing history